9 Bladder Cancer Clinical Trials in Boston, NY (2026)

Q: How do I join a clinical trial in Boston?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Boston research site will contact you.

Recruiting Bladder Cancer Studies in Boston

NCT05874921Recruiting

uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

The purpose of this registry is to evaluate real world experience and outcomes of patients with Upper Tract Urothelial Cancer (UTUC) treated with Jelmyto in the United States....

Boston, NY400 participantsUroGen Pharma Ltd.

View Study Details

NCT06138561Recruiting

Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments

The goal of this study is to better understand how to best treat participants with advanced bladder cancer who may not be able to tolerate all of the chemotherapy drugs that have been shown to be effe...

Boston, NY180 participantsDana-Farber Cancer Institute

View Study Details

NCT03216525Recruiting

Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol

To determine if Alvimopan during open or robotic radical cystectomy with urinary diversion results in quicker return of bowel function (GI-2 recovery = time to upper \[first toleration of solid food\]...

Boston, NY136 participantsBrigham and Women's Hospital

View Study Details

NCT05929235Recruiting

A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma

The goal of this clinical trial is to study the safety and tolerability in all advanced solid tumors, including advanced urothelial carcinoma. The main question\[s\] it aims to answer are: * Is FX-9...

Boston, NY120 participantsFlare Therapeutics Inc.

View Study Details

NCT04724018Recruiting

Sacituzumab Govitecan Plus EV in Metastatic UC

Phase I of this research study will assess what doses of Sacituzumab Govitecan and Enfortumab Vedotin can be safely combined in the treatment of metastatic urothelial carcinoma (mUC). In Phase II of t...

Boston, NY106 participantsDana-Farber Cancer Institute

View Study Details

NCT04442724Recruiting

Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy

The purpose of this study is to examine the usefulness of implanting small 24-K gold fiducial markers around a bladder tumor site, so that a Radiation Oncologist can identify the original tumor locati...

Boston, NY60 participantsCedars-Sinai Medical Center

View Study Details

NCT03317158Recruiting

Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the Bladder

Upon successful screening and registration, enrollment to durvalumab monotherapy (cohort 1) will begin. If DLT criteria outlined in the protocol are exceeded with durvalumab monotherapy (cohort 1), th...

Boston, NY55 participantsNoah Hahn, M.D.

View Study Details

NCT05519241Recruiting

A Phase I Intravesical PPM Therapy for NMIBC

This clinical trial is to determine the safety and effectiveness of an investigational bladder cancer drug named "PLZ4-coated paclitaxel-loaded nanoscale micelle (PPM)." PPM is tiny particles that con...

Boston, NY29 participantsVA Office of Research and Development

View Study Details

NCT05715684Recruiting

Patient-Centered Surgical Prehabilitation

The purpose of this research is to validate the prehabilitation program which is defined as a set of interventions meant to prepare the body physically and nutritionally for the cystectomy procedure....

Boston, NY25 participantsDana-Farber Cancer Institute

View Study Details

About Bladder Cancer Clinical Trials in Boston

Bladder cancer occurs in the tissues of the bladder and is one of the most common cancers. It has a high recurrence rate, requiring ongoing monitoring. Treatments include surgery, intravesical therapy, chemotherapy, and immunotherapy.

There are currently 9 bladder cancer clinical trials recruiting participants in Boston, NY. These studies are seeking a combined 1,111 participants. Research is being sponsored by UroGen Pharma Ltd., Dana-Farber Cancer Institute, Brigham and Women's Hospital and 4 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Bladder Cancer Clinical Trials in Boston — FAQ

Are there bladder cancer clinical trials in Boston?

Yes, there are 9 bladder cancer clinical trials currently recruiting in Boston, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Boston?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Boston research site will contact you about next steps.

Are clinical trials in Boston free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Boston studies also compensate for your time and travel.

What bladder cancer treatments are being tested?

The 9 active trials in Boston are testing new therapies including novel drugs, biologics, and treatment approaches for bladder cancer.

Data updated July 13, 2026 from ClinicalTrials.gov